Abraxane and Temodar Plus Genasense in Advanced Melanoma

NCT00409383 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Genasense® (oblimersen)
DRUG: Abraxane® (paclitaxel protein-bound particles for injectable suspension)
DRUG: Temodar® (temozolomide)

Sponsor

Genta Incorporated